21st Century Cures Act
The 21st Century Cures Act was enacted in 2016 and was meant to provide the necessary resources required to enhance biomedical studies and clinical trials. The objective of the legislation was to remove the barriers that were hindering experimental studies and the exchange of data (Majumder et al. 2017).
Impact of the policy or regulation on system implementation
The regulation has caused major changes in healthcare, mostly in mental health, health information technology, funding, and FDA (Hudson & Collins, 2017). The regulation has promoted the application of low-risk devices and data interoperability in enhancing the sharing of health data and the promotion of outcome-based care provision practices (McGonigle & Mastrian, 2017). Access to these data is restricted to people without the right credentials.
Impact of the policy on clinical care, patient/provider interactions, and workflow
The implementation of the regulation has enhanced the availability of patient electronic health data to the authorized providers. The system promotes the availability of research findings, facts, or any other information from HHS (Hudson & Collins, 2017). This has promoted the quality of clinical care and better interactions of patients and providers (Sarpatwari & Kesselheim, 2015). The system enhances the patient processing process and better access to the patient’s history, which has improved handing over and the workflow.
Organizational policies and procedures
Some of the organization policies that relate to the implementation of the Act include; protection of researchers and data and promotion of data security, the procedure for health information networks advancement through interoperability, improvement of access of the patient to their electronic data and the integration policy of IT frameworks in the enhancement of the clinical researches and care (Sarpatwari & Kesselheim, 2015).